Oncology Institute (TOI) Accumulated Expenses (2019 - 2026)

Oncology Institute has reported Accumulated Expenses for 8 years, with the latest figure at $24.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 3.68% year-over-year to $24.3 million; the trailing twelve-month figure through Mar 2026 stood at $24.3 million (up 3.68% YoY), and the FY2025 full-year result was $20.6 million, down 2.15% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $24.3 million, up from $20.6 million in the prior quarter.
• The five-year high for Accumulated Expenses was $24.3 million in Q1 2026, with the low at $12.2 million in Q1 2023.
• Historically, Accumulated Expenses has averaged $17.5 million across 5 years, with a median of $16.1 million in 2022.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 18045.0% — and 2023, when it fell 21.21%.
• Oncology Institute's Accumulated Expenses stood at $14.6 million in 2022, then dropped by 4.1% to $14.0 million in 2023, then surged by 50.71% to $21.1 million in 2024, then retreated by 2.15% to $20.6 million in 2025, then advanced by 17.72% to $24.3 million in 2026.
• The last three Accumulated Expenses figures came in at $24.3 million (Q1 2026), $20.6 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.